YD Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	621	45	47	50
Market Cap Growth	1267.11%	-4.31%	-5.87%	-
Enterprise Value	628	43	-	-
Last Close Price	8.43	11.25	11.03	10.43
PE Ratio	-	-	3497.13	-
PS Ratio	1237.31	88.92	135.44	138.36
PB Ratio	1.84	6.89	2062.32	5396.83
P/TBV Ratio	161.49	11.61	2062.32	5396.83
P/FCF Ratio	-	-	-	720.26
P/OCF Ratio	-	-	-	720.26
EV/Sales Ratio	1231.21	83.59	-	-
Debt / Equity Ratio	0.00	0.00	2.07	13.30
Debt / EBITDA Ratio	-	-	1.18	6.81
Debt / FCF Ratio	-	-	-	1.77
Net Debt / Equity Ratio	-0.47	-0.47	-1.72	10.07
Net Debt / EBITDA Ratio	2.29	2.29	5.34	-2.28
Net Debt / FCF Ratio	1.63	1.63	0.71	1.34
Asset Turnover	0.14	0.14	1.28	-
Inventory Turnover	6.65	6.65	3.64	-
Quick Ratio	12.91	12.91	0.62	0.40
Current Ratio	13.18	13.18	0.91	0.75
Return on Equity (ROE)	-42.69%	-42.69%	83.89%	-
Return on Assets (ROA)	-25.43%	-25.43%	-2.25%	-
Return on Invested Capital (ROIC)	-42.01%	-84.41%	-17.44%	-43.47%
Return on Capital Employed (ROCE)	-22.10%	-22.10%	-42.80%	-79.40%
Earnings Yield	-0.22%	-3.11%	0.03%	-0.10%
FCF Yield	-0.30%	-4.21%	-0.12%	0.14%
Buyback Yield / Dilution	-4.01%	-4.01%	-	-

Updated Apr 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q